• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

CVS Must Be Taking Its Own Medicine: It's Looking Healthy

The charts of CVS are in good shape, so expect renewed strength in the weeks ahead.
By BRUCE KAMICH
May 04, 2020 | 02:49 PM EDT
Stocks quotes in this article: CVS

During Friday's "Mad Money" program, host Jim Cramer pointed out several companies that are reporting earnings this week: On Wednesday CVS Health (CVS)  reports along with others. Cramer was bullish on CVS. 

 
We reviewed the charts of CVS on March 17, writing that "Technical analysis can be subjective at times. I could easily write something bearish about CVS and no one would blink. I can also find some bullish clues Monday morning, but the weakness in the broad market could easily dominate. For now, let's keep an open mind that CVS has corrected enough and that buyers could be attracted around current levels." As it turns out, that was the low for CVS. 
 
Let's look at some updated charts and indicators.  
 
In this daily Japanese candlestick chart of CVS, below, we can see the low in the middle of March and the successful retests of that low in the second half of the month. Prices moved higher from late March to late April and have corrected slightly in recent sessions. The April rally stopped at the underside of the rising 200-day moving average line and declined so far to retest the declining 50-day moving average line. The $60-$59 area could provide some chart support and the trading volume looks like it has dried up in April. The On-Balance-Volume (OBV) line moved up from late March and shows only a limited decline in recent days. The Moving Average Convergence Divergence (MACD) oscillator has narrowed towards a bearish crossover and a take-profits sell signal. 
 
 
 
In this updated weekly chart of CVS, below, we see a chart that has bullish potential. Prices are below the rising 40-week moving average line. The weekly OBV line is working on a turn around from its March low. The MACD oscillator is narrowing towards a potential cover-shorts buy signal. 
 
  
In this daily Point and Figure chart of CVS, below, we can see that the software is projecting a possible downside price target of $54 however there looks like strong support at current levels and below.  
 
 
 
Bottom line strategy: I think the charts of CVS are in pretty good shape, and I look for renewed strength in the days and weeks ahead. Some traders seem to be more influenced by the broad market sell off in recent days. 
 

(CVS is a holding in Jim Cramer's Action Alerts PLUS member club. Want to be alerted before Jim Cramer buys or sells this stock? Learn more now.)

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Technical Analysis | Health Care Equipment & Services | Healthcare | Pharmaceuticals | Mad Money | Earnings Preview

More from Investing

If You Think the Selling Started Yesterday, You Have a Short Memory

Helene Meisler
Jan 28, 2021 6:00 AM EST

A lot of what we saw on Wednesday has been in the works for a while now.

Emotions Run High as Indexes Slip

James "Rev Shark" DePorre
Jan 27, 2021 4:44 PM EST

I've raised a bit of cash, but it's still unclear what will emerge from here.

'Mortal Kombat' on the Market

Peter Tchir
Jan 27, 2021 3:54 PM EST

Let's pick apart the wild action in individual stocks -- especially GameStop -- and see what to expect going forward.

Butterflies Are Free: This GameStop Options Play Is Hardly Ever Seen

Timothy Collins
Jan 27, 2021 3:01 PM EST

I'll take a 66% risk-free rate of return in six months anytime.

Walgreens Boots Alliance Rallies Ahead of Earnings

Bruce Kamich
Jan 27, 2021 2:45 PM EST

Has WBA rallied too much?

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:48 AM EST STEPHEN GUILFOYLE

    Cashing in Some More Chips at Stocks Under $10

    We're trimming a position for a big gain today.
  • 08:34 AM EST GARY BERMAN

    Wednesday Morning Fibocall for 1/27/2021

    The "correction" can be coming sooner than we thou...
  • 09:35 AM EST CHRIS VERSACE

    Another Big Winner for Stocks Under $10

    We're ringing the register Tuesday morning.
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login